Floatz logo

HEPATITIS C IMMUNE GLOBULIN INTRAVENOUS (HUMAN)

Hepatitis, Viral, Human

Biotest Pharmaceuticals Corporationother_biologicalPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hepatitis, Viral, Human cohort.

Asset / SponsorPhaseRating
Ethiodized Oil
ANRS, Emerging Infectious Diseases
Phase 3BB

Same molecule, other indications

HEPATITIS C IMMUNE GLOBULIN INTRAVENOUS (HUMAN) is also rated in:

hepatitis C virus infectionDormant
BB
Indicative ·
64 / 100
View asset →
viral infectious diseaseDormant
BB
Indicative ·
64 / 100
View asset →
cirrhosis of liverDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →